Skip to search boxSkip to navigationSkip to main content

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: Results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women's Ischemia Syndrome Evaluation (WISE)

  • Chrisandra Shufelt
    ,
  • Philip Bretsky
    ,
  • Cristina M. Almeida
    ,
  • B. Delia Johnson
    ,
  • Leslee J. Shaw
    ,
  • Ricardo Azziz
  • Cedars-Sinai Medical Center
    ,
  • University of Pittsburgh
    ,
  • Emory University
    ,
  • ,
  • University of Florida
    ,
  • University of Alabama at Birmingham
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Context: Dehydroepiandrosterone sulfate (DHEA-S), a major circulating sex steroid prohormone, declines with age. Low levels have been associated with increased cardiovascular disease (CVD) risk and all-cause mortality, although these results have not been consistently replicated, particularly in women. Objective: Our objective was to examine the association of circulating DHEA-S levels, CVD, and mortality risk among postmenopausal women with suspected myocardial ischemia. Design: In the Women's Ischemia Syndrome Evaluation, 270 postmenopausal women underwent coronary angiography and blood hormone levels for suspected ischemia and were followed annually. The primary outcome of interest was CVD mortality; secondary analyses included all-cause mortality and nonfatal CVD events (myocardial infarction, stroke, and congestive heart failure) and angiographic obstructive coronary artery disease (CAD). Results: Women in the lowest DHEA-S tertile had higher CVD mortality (17% 6-yr mortality rate vs. 8%; log-rank P = 0.011), and all-cause mortality (21 vs. 10%; P = 0.011) compared with women with higher DHEA-S levels. The increased CVD mortality risk [hazard ratio (HR) = 2.55; 95% confidence interval (CI) = 1.19-5.45] remained unchanged after adjustment for multiple CVD risk factors (HR = 2.43; 95% CI = 1.06-5.56) but became nonsignificant when further adjusting for the presence or severity of angiographic obstructive CAD (HR = 1.99; 95% CI = 0.87-4.59). Results were similar for all-cause mortality. Lower DHEA-S levels were only marginally but not independently associated with obstructive CAD. Conclusions: Among postmenopausal women with coronary risk factors undergoing coronary angiography for suspected myocardial ischemia, lower DHEA-S levels were linked with higher CVD mortality and all-cause mortality. Our study provides valuable feasibility data useful for future investigations and possible mechanistic pathways.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 4985-4992 (8 pages)

Journal (Volume, Issue Number)

Journal of Clinical Endocrinology and Metabolism (Volume 95, Issue 11)

Publication milestones

  • Published - 11/2010

Publication status

Published - 11/2010

ISSN

0021-972X

Publication IDs

  • Scopus: 78049520519
  • PubMed: 20739385

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.08
Fractional count
11
Fractional count
0.92
Fractional count
1
Fractional count
1
SciVal
citations
68
SciVal
FWCI
1.94
SciVal
Author count
12
SciVal
Paper percentile
93
SciVal
Top percentile
10

PlumX, opens in new tab

Citation count
105
Social media
9
Mentions
1
Captures
47

Funding Details

This work was supported by contracts from the National Heart, Lung, and Blood Institute , nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164 , a GCRC Grant MO1-RR00425 from the National Center for Research Resources , and grants from the Gustavus and Louis Pfeiffer Research Foundation (Denville, NJ), The Women's Guild of Cedars-Sinai Medical Center (Los Angeles, CA), The Ladies Hospital Aid Society of Western Pennsylvania (Pittsburgh, PA), the Edythe L. Broad Endowment, Cedars-Sinai Medical Center (Los Angeles, CA), and the Barbra Streisand Women's Cardiovascular Disease Research and Education Program, Cedars-Sinai Medical Center.
FundersFunding numbers
The Edythe L. Broad Endowment
-
Ladies Hospital Aid Society of Western Pennsylvania
-
NHLBI
MO1-RR00425, N01-HV-68161, N01-HV-68163, N01-HV-68162, N01-HV-68164
NCRR
-
Gustavus and Louise Pfeiffer Research Foundation
-
CS
-